He’s a revolutionary in the area of nutrition. Dr. Karl Dawson, Chief Scientific Officer, Alltech, took the stage the opening session of the 2012 International Symposium. The company is doing breakthrough research in nutrigenomics to find new ways to feed our animals to enhance their performance, health and longevity and enhance the consumer experience. Dr. Dawson also talks about how Alltech is branching out into new research strategies for addressing human health and wellness. I interviewed Dr. Dawson during the press conference held after the opening session and have included it as well as Dr. Dawson’s remarks on stage this morning.
Listen to my interview with Dr. Dawson here: Interview with Dr. Karl Dawson
Listen to Dr. Dawson’s remarks here: Dr. Karl Dawson Remarks
2012 Alltech International Symposium Photo Album
“The carcass of the animal is being held under State authority at a rendering facility in California and will be destroyed. It was never presented for slaughter for human consumption, so at no time presented a risk to the food supply or human health. Additionally, milk does not transmit BSE,” said USDA Chief Veterinary Officer John Clifford. “Samples from the animal in question were tested at USDA’s National Veterinary Services Laboratories in Ames, Iowa. Confirmatory results using immunohistochemistry and western blot tests confirmed the animal was positive for atypical BSE, a very rare form of the disease not generally associated with an animal consuming infected feed.”
He told other swine vets at the 
The need for more training of meat-counter employees became evident after Merck Animal Health conducted a series of consumer panels that revealed consumers identify the staff behind the counter as experts. “The consumer that goes to the retail store today still sees the person behind the counter in a white coat as the butcher and they expect them to have vast knowledge of the beef products they’re selling,” said Kyle Pfieffer with Merck Animal Health, who notes that the need for training was quickly confirmed during retailer discussions.
It has been o
New results from a trial done in Minnesota show that the PRRS modified live virus vaccine appears to reduce viral shedding. 
The focus of the partnership will target the development of products using Verenium enzymes for the global poultry, swine, beef, dairy, aquaculture and companion animals markets. “These new enzyme products will give us the ability to offer new solutions to the performance challenges our customers face,” said Novus International president and CEO Thad Simons.
“We are extremely enthusiastic about our partnership with Novus, the potential opportunity it represents for the continued development of our pipeline and for Verenium to become a more active participant in the animal health and nutrition marketplace with our suite of high-performance enzyme products,” said James Levine, President and Chief Executive Officer at Verenium. 
